Growth Metrics

Innoviva (INVA) Total Debt Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 5.94%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 103.99%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.07%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn -42.50%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -42.50%
Dec 31, 2025 -42.51%
Sep 30, 2025 -42.53%
Jun 30, 2025 0.37%
Mar 31, 2025 0.48%
Dec 31, 2024 0.47%
Sep 30, 2024 0.47%
Jun 30, 2024 0.47%
Mar 31, 2024 0.46%
Dec 31, 2023 -17.42%
Sep 30, 2023 -17.43%
Jun 30, 2023 363.40%
Mar 31, 2023 363.14%
Dec 31, 2022 36.92%
Sep 30, 2022 37.60%
Jun 30, 2022 -75.37%
Mar 31, 2022 -75.24%
Dec 31, 2021 2.37%
Sep 30, 2021 2.33%
Jun 30, 2021 2.30%
Mar 31, 2021 2.26%
Dec 31, 2020 2.23%
Sep 30, 2020 -1.36%
Jun 30, 2020 -1.41%
Mar 31, 2020 -1.45%
Dec 31, 2019 -1.50%
Sep 30, 2019 2.01%
Jun 30, 2019 -20.52%
Mar 31, 2019 -20.60%
Dec 31, 2018 -36.12%
Sep 30, 2018 -36.86%
Jun 30, 2018 16.94%
Mar 31, 2018 2.82%
Dec 31, 2017 -16.30%
Sep 30, 2017 25.34%
Jun 30, 2017 -14.07%
Mar 31, 2017 -2.50%
Dec 31, 2016 48.52%
Sep 30, 2016 -1.54%
Jun 30, 2016 0.16%
Mar 31, 2016 1.35%
Dec 31, 2015 2.24%
Sep 30, 2015 6.30%
Jun 30, 2015 7.41%
Dec 31, 2014 1,078.96%
Dec 31, 2011 -74.91%